SMN1 Gene News and Research

RSS
Using Whole Exome Sequencing and Carrier Screening Tests for Birth Defects

Using Whole Exome Sequencing and Carrier Screening Tests for Birth Defects

Study examines safety and early outcomes of gene therapy for spinal muscular atrophy

Study examines safety and early outcomes of gene therapy for spinal muscular atrophy

Adult SMA patients treated with Nusinersen show improvement in motor function

Adult SMA patients treated with Nusinersen show improvement in motor function

Study findings highlight importance of early detection of SMA through newborn screening

Study findings highlight importance of early detection of SMA through newborn screening

Investigational drug may help increase protein levels in babies with spinal muscular atrophy

Investigational drug may help increase protein levels in babies with spinal muscular atrophy

Johns Hopkins researchers identify new biological target for treating spinal muscular atrophy

Johns Hopkins researchers identify new biological target for treating spinal muscular atrophy

Promising new therapeutic target could lead to better prognosis of spinal muscular atrophy

Promising new therapeutic target could lead to better prognosis of spinal muscular atrophy

Positive data from two studies analyzing Good Start's test for inherited diseases presented at ACOG 2015

Positive data from two studies analyzing Good Start's test for inherited diseases presented at ACOG 2015

MU researchers make new breakthrough in spinal muscular atrophy drug

MU researchers make new breakthrough in spinal muscular atrophy drug

Study: Sufficient copies of SMN1 gene extend survival in animals with spinal muscular atrophy

Study: Sufficient copies of SMN1 gene extend survival in animals with spinal muscular atrophy

Joint research program in SMA enters initial stage of clinical development

Joint research program in SMA enters initial stage of clinical development

Research Institute receives Fast Track status for its gene therapy product for treatment of SMA

Research Institute receives Fast Track status for its gene therapy product for treatment of SMA

Researchers develop TSUNAMI method to create animal model of adult-onset version of SMA

Researchers develop TSUNAMI method to create animal model of adult-onset version of SMA

Two CUMC studies provide new insights into spinal muscular atrophy

Two CUMC studies provide new insights into spinal muscular atrophy

Investigators discover biological explanation for why low levels of oxygen advance SMA symptoms

Investigators discover biological explanation for why low levels of oxygen advance SMA symptoms

PTC, Roche announce licensing agreement for SMA programme

PTC, Roche announce licensing agreement for SMA programme

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

Enzo Life Sciences introduces ELISA system to detect SMN protein

Enzo Life Sciences introduces ELISA system to detect SMN protein

Repligen third quarter total revenue increases 26% to $7,068,000

Repligen third quarter total revenue increases 26% to $7,068,000

Cedars-Sinai receives California Institute grant to develop new technique for specific diseases

Cedars-Sinai receives California Institute grant to develop new technique for specific diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.